ResourceSeparations
Utilization of the ACQUITY PREMIER System and columns for improved oligonucleotide bioanalytical chromatographic performance
19 Feb 2021In this application note, Waters highlights the increased chromatographic performance for oligodeoxythymidines (ODTs) and the oligonucleotide antisense therapy, GEM91, using the ACQUITY PREMIER chromatographic system.
Related Products
Request Quote for All Products
ACQUITY Premier System
WatersAlong with the reliability, ruggedness, high quality, and configuration flexibility you expect from the ACQUITY™ UPLC™ PLUS Series, the Waters™ ACQUITY Premier System delivers a step change in chromatographic performance, lab efficiency, and risk control.